ME-143, a novel inhibitor of tumor-specific NADH oxidase (tNOX): Results from a first-in-human phase I study

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2012
This article has no abstract
Epistemonikos ID: f71d1705bed82e7a8c7733d3e339f552dc1c6fa7
First added on: Feb 05, 2025